Healthcare

Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations

WARSAW, Ind., Sept. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today…

4 months ago

P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services

LEUVEN, Belgium, Sept. 5, 2024 /PRNewswire/ -- P95 BV ("P95"), a leading global provider of epidemiology and clinical solutions with a specialty…

4 months ago

Magellan Health Launches Mental Wellbeing App for Young People

Powered by BeMe Health, the mobile app provides resources and support to address real-time mental health needs for teenagers and…

4 months ago

Exer AI Collaborates with Mayo Clinic to Advance Standard of Care for Hand and Wrist Disorders with AI

DENVER, Sept. 5, 2024 /PRNewswire/ -- Exer AI, a clinical AI company addressing musculoskeletal (MSK) and movement disorders, today announced a…

4 months ago

WindRose Health Investors Makes Strategic Investment in MyndYou

Proven Conversational AI Solution Supports Next Generation of Population Health Management NEW YORK, Sept. 5, 2024 /PRNewswire/ -- WindRose Health…

4 months ago

Kain Capital Launches Kain Analytics

Dedicated in-house team designs and implements automation and AI solutions that bring better measurement tools and efficiency to healthcare services…

4 months ago

HMR and Profile Plan Unite to Provide Enhanced Health and Weight-Loss Solutions

SIOUX FALLS, SD / ACCESSWIRE / September 5, 2024 / HMR Plan, a leading provider of weight-loss solutions since 1983,…

4 months ago

Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

CE Mark approval opens European market for TRUVIEW system ANN ARBOR, MI / ACCESSWIRE / September 5, 2024 / Zomedica…

4 months ago

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North…

4 months ago

Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage…

4 months ago